Risk of readmission among individuals with cannabis use disorder during a 15‐year cohort study: the impact of socio‐economic factors and psychiatric comorbidity
Addiction · 2023
DOI: 10.1111/add.16158 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Addiction, 2023. Verfasst von Rynaz Rabiee und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Global Public Health, Karolinska Institutet, Stockholm, Sweden. Hauptthemen laut MEDLINE: Marijuana Abuse, Substance-Related Disorders, Cannabis. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Forskningsrådet om Hälsa, Arbetsliv och Välfärd, Vetenskapsrådet.
Abstract (Originalsprache)
Background and aim Cannabis use disorder (CUD) is one of the main reasons for seeking substance treatment in the Nordic countries, but there are few studies on readmission to care. We aimed to characterize CUD readmission and estimate the magnitude of how socio‐economic factors and psychiatric comorbidity influence the risk of CUD readmission. Design, Setting and Participants This was a nation‐wide cohort study carried out between 2001 and 2016 in Sweden. The participants were individuals with CUD, aged 17 years and above ( n = 12 143).
Measurements
Information on predictors was obtained from registers and included education, income and psychiatric comorbidity assessed by six disease groups. The outcome measure was readmission, defined as a CUD visit to health‐care at least 6 months after initial CUD diagnosis. Hazard ratios (HR) were estimated using Cox survival analyses and flexible parametric survival analyses to assess risk of readmission and how the risk varied with age.
Findings
The vast majority of CUD visits took place in outpatient care (~80%). Approximately 23% of the included individuals were readmitted to care during follow‐up. The fully adjusted model showed an increased risk of readmission among those with schizophrenia and other psychotic disorders [HR = 1.54, 95% confidence interval (CI) = 1.29–1.84], low education (HR = 1.40, 95% CI = 1.24–1.57), personality disorders (HR = 1.27, 95% CI = 1.05–1.54) or mood disorders (HR = 1.27, 95% CI = 1.12–1.45). Flexible parametric modeling revealed increased risk of readmission mainly in individuals aged 18–35 years.
Conclusions
The risk of readmission was highest among those with low education, schizophrenia and other psychotic disorders, mood‐related disorders or personality disorders. Individuals aged 18–35 years showed the highest risk of readmission. Our findings highlight individuals with complex health‐care needs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Global Public Health, Karolinska Institutet, Stockholm, Sweden.
- Center for Epidemiology and Community Medicine, Region Stockholm, Stockholm, Sweden.
ORCID-Profile: Rynaz Rabiee, Emilie Agardh
Förderung
- Forskningsrådet om Hälsa, Arbetsliv och Välfärd
- Vetenskapsrådet
Zitieren
APA
Rabiee, R., Sjöqvist, H., Agardh, E., Lundin, A., & Danielsson, A. K. (2023). Risk of readmission among individuals with cannabis use disorder during a 15‐year cohort study: the impact of socio‐economic factors and psychiatric comorbidity. Addiction. https://doi.org/10.1111/add.16158
Vancouver
Rabiee R, Sjöqvist H, Agardh E, Lundin A, Danielsson AK. Risk of readmission among individuals with cannabis use disorder during a 15‐year cohort study: the impact of socio‐economic factors and psychiatric comorbidity. Addiction. 2023. doi:10.1111/add.16158
BibTeX
@article{Rabiee2023,
author = {Rabiee, Rynaz and Sjöqvist, Hugo and Agardh, Emilie and Lundin, Andreas and Danielsson, Anna-Karin},
title = {Risk of readmission among individuals with cannabis use disorder during a 15‐year cohort study: the impact of socio‐economic factors and psychiatric comorbidity},
journal = {Addiction},
year = {2023},
doi = {10.1111/add.16158}
}
EUVIMED